Health risk of fluorine in soil from a phosphorus industrial area based on the in-vitro oral, inhalation, and dermal bioaccessibility.

Health risk of F in soil is of special concern due to the continuously elevated concentration of F in soil. However, there is still a dearth of risk assessments of F in soil based on in-vitro bioaccessibility posed by multiple exposure routes. Herein, the oral, inhalation, and dermal bioaccessibility of F in soil was firstly obtained by adapting and combining in-vitro methods, which then was introduced to remedy an information gap of a comprehensive risk of F in soil posed by a multi-exposure pathway. Combined in-vitro tests indicate the oral, inhalation, and dermal bioaccessibility of F was 13.15 ± 2.63%, 16.55 ± 2.63%, and 1.27 ± 0.73%, respectively. Plasma yielded a detoxic potential for the absorbed F after digesting in small intestine, while effects of enzymes, sweat, and food on the oral bioaccessibility of F were insignificant. Different with metals, the major dissolving phase of F was the interstitial fluid in the deep lung instead of in the alveolar macrophages intracellular environment. A potentially major release of F in the exocrine sweat was noted than in the apocrine sweat. Risk assessments based on the daily exposure incorporated with the in-vitro bioaccessibility suggested that compared with inhalation and dermal contact, oral ingestion was the main exposure route of F in soil to human. Present findings provide insights into the bioaccessibility and health risk of F in soil by multiple exposure routes, which are crucial for the risk control of F contamination in soil.